Brief: Schott Pharma Q1 Revenues Of EUR 230 Million

SCHOTT Pharma AG & Co KgaA

13/02/2025 06:03

Feb 13 (Reuters) - SCHOTT Pharma AG & Co KgaA  1SXP.DE :
    * EQS-NEWS: SCHOTT PHARMA RECORDS GOOD START INTO FISCAL
YEAR AND
CONFIRMS FULL YEAR OUTLOOK
    * SCHOTT PHARMA AG & CO KGAA - Q1 2025 REVENUES REACHED EUR
230M;
DECREASE OF 1% YOY AS REPORTED OR INCREASE OF 4% AT CONSTANT
CURRENCIES
    * SCHOTT PHARMA AG & CO KGAA - Q1 2025 EBITDA MARGIN OF
25.1% AS
REPORTED OR 26.3% AT CONSTANT CURRENCIES
    * SCHOTT PHARMA AG & CO KGAA - BUSINESS WELL ON TRACK TO
DELIVER
ALL 2025 TARGETS
    * SCHOTT PHARMA AG & CO KGAA - CONFIRMS ITS FISCAL YEAR 2025
TARGETS

Source text:  ID:nEQ3cYY97a 
Further company coverage:  1SXP.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))